Abstract
The permeability of the blood-brain barrier (BBB) to immunoreactive alpha-melanotropin (α-MSH) was quantified in rats pretreated with monosodium l-glutamic acid to deplete their CNS stores of endogenous α-MSH. The methodology, suitable for poorly permeable substances, monitored blood and brain tissue concentrations of α-MSH over 15 min following intravenous injection of 30 nmol synthetic α-MSH. Rate constants for entry of α-MSH into brain tissue were estimated from separate nonlinear least-squares fits of connecting two- and one-compartment open models to plasma and extravascular brain tissue concentration data, respectively. Comparisons were made to rate constants measured similarly for 14C-inulin. The BBB had a low permeability to immunoreactive α-MSH, consistent with peptide penetrating the barrier by passive diffusion dependent upon the lipid solubility of the molecule.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Banks WA, Kastin AJ (1985a) Permeability of the blood-brain barrier to neuropeptides: the case for penetration. Psychoneuroendocrinology 10:385–399
Banks WA, Kastin AJ (1985b) Peptides and the blood-brain barrier: lipophilicity as a predictor of permeability. Brain Res Bull 15:287–292
Beckwith BE, Sandman CA (1978) Behavioral influences of the neuropeptides ACTH and MSH: a methodological review. Neurosci Biobehav Rev 2:311–338
Cornbleet PJ, Gochman N (1979) Incorrect least-squares regression coefficients in method comparisons analysis. Clin Chem 25:432–438
Cornford EM, Braun LD, Crane PD, Oldendorf WH (1978) Blood-brain barrier restriction of peptides and the low uptake of enkephalins. Endocrinology 103:1297–1303
De Rotte AA, Bouman HJ, van Wimersma Greidanus TjB (1980) Relationships between α-MSH levels in blood and in cerebrospinal fluid. Brain Res Bull 5:375–381
De Wied D (1978) Behavioural effects of neuropeptides related to β-LPH. In: Hughes J (ed) Centrally acting peptides. Macmillan Press, London, pp 241–251
Dupont A, Kastin AJ, Labrie F, Pelletier G, Puviani R, Schally AV (1975) Distribution of radioactivity in organs of the rat and mouse after injection of [125I] α-melanocyte-stimulating hormone. J Endocrinol 64:237–241
Eskay RL, Brownstein MJ, Long RT (1979) α-Melanocyte-stimulating hormone: reduction in adult rat brain after monosodium glutamate treatment of neonates. Science 205:827–829
Fenstermacher JD, Blasberg RG, Patlak CS (1981) Methods for quantifying the transport of drugs across brain barrier systems. Pharmacol Ther 14:217–248
Greenberg R, Whalley CE, Jourdikian F, Mendelson IS, Walter R, Nikolics K, Coy DH, Schally AV, Kastin AJ (1976) Peptides readily penetrate the blood-brain barrier: uptake of peptides by synaptosomes is passive. Pharmacol Biochem Behav [Suppl 1] 5:151–158
Kastin AJ, Nissen C, Nikolics K, Medzihradszky K, Coy DH, Teplan I, Schally AV (1976) Distribution of 3H-α-MSH in rat brain. Brain Res Bull 1:19–26
Kastin AJ, Olson RD, Schally AV, Coy DH (1979) CNS effects of peripherally administered brain peptides. Life Sci 25:401–414
La Du BN, Mandel HG, Way EL (1971) Fundamentals of drug metabolism and drug disposition. Williams & Wilkins, Baltimore
McIntosh JEA, McIntosh RP (1980) Mathematical modelling and computers in endocrinology. Springer Verlag, Berlin Heidelberg New York
Meisenberg G, Simmons WH (1983) Peptides and the blood-brain barrier. Life Sci 32:2611–2623
O'Donohue TL, Dorsa DM (1982) The opiomelanotropinergic neuronal and endocrine systems. Peptides 3:353–395
Ohno K, Pettigrew KD, Rapoport SI (1978) Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat. Am J Physiol 235:H299-H307
Oldendorf WH (1975) Permeability of the blood-brain barrier. In: The basic neurosciences. The nervous system, vol 1. Tower DB (ed) Raven Press, New York, pp 279–289
Olney JW (1969) Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 164:719–721
Pardridge WM, Mietus LJ (1981) Enkephalin and blood-brain barrier: studies of binding and degradation in isolated brain microvessels. Endocrinology 109:1138–1143
Pelletier G, Labrie F, Kastin AJ, Schally AV (1975) Radioautographic localization of radioactivity in rat brain after intracarotid injection of 125I-α-melanocyte-stimulating hormone. Pharmacol Biochem Behav 3:671–674
Rapoport SI, Klee WA, Pettigrew KD, Ohno K (1980) Entry of opioid peptides into the central nervous system. Science 207:84–86
Sharma RR, Vimal RLP (1984) Theoretical interpretation of extraction (in brain) of peptides including concentration variations. Brain Res 308:201–214
Wilson JF, Morgan MA (1979a) A radioimmunoassay for alpha-melanotropin in rat plasma. J Pharmacol Methods 2:97–116
Wilson JF, Morgan MA (1979b) α-Melanotropin-like substances in the pituitary and plasma of Xenopus laevis in relation to colour change response. Gen Comp Endocrinol 38:172–182
Wilson JF, Anderson S, Snook G, Llewellyn KD (1984) Quantification of the permeability of the blood-CSF barrier to α-MSH in the rat. Peptides 5:681–685
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wilson, J.F. Low permeability of the blood-brain barrier to nanomolar concentrations of immunoreactive alpha-melanotropin. Psychopharmacology 96, 262–266 (1988). https://doi.org/10.1007/BF00177572
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00177572